U.S. Congress legislation · 119th Congress
HB2592: Aviation Medication Transparency Act of 2025
Status: In committee, September 15, 2026
To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes.
What the bill says
To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes.
From the introduced text, April 2, 2025:
A BILL To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes. SECTION 1. Short title This Act may be cited as the Aviation Medication Transparency Act of 2025 . SECTION 2. List of approved medications (a) In general Not later than 1 year after the date of enactment of this Act, the Administrator of the Federal Aviation Administration shall publish and maintain on a publicly available website of the Administration the list of medications and treatments that may be safely prescribed to an airman to treat certain medical conditions that the Administrator has compiled for purposes of the issuance of a medical certification to an airman. (b) Requirements The list required under subsection (a) shall-- (1) be drafted in consultation with-- (A) the Aeromedical Innovation and Modernization Working Group; (B) the certified exclusive bargaining representatives of air traffic controllers of the Administration certified under section 7111 of title 5, United States Code; (C) the principal organization representing the largest certified collective bargaining representative of airline pilots; and (D) any other stakeholder determined relevant by the task group, including any stakeholders described in section 411(d)(3)(B) of the FAA Reauthorization Act of 2024; (2) be comprehensive; (3) be drafted …
Sponsors
- Sean Casten (D, HD-006) · primary sponsor
- Pete Stauber (R, HD-008)
- Balint, Becca (D, HD-000)
- Michael Lawler (R, HD-017)
- Betty McCollum (D, HD-004)
- Kristen McDonald Rivet (D, HD-MI-8)
- Chuck Edwards (R, HD-NC-11)
- Bonnie Watson Coleman (D, HD-012)
- Deborah Ross (D, HD-002)
- Josh Harder (D, HD-CA-9)
- Jennifer Kiggans (R, HD-002)
- Monica De La Cruz (R, 15)
Latest actions
- : Ordered to be Reported (Amended) by Voice Vote.
- : Committee Consideration and Mark-up Session Held
- : Subcommittee on Aviation Discharged
- : Referred to the Subcommittee on Aviation.
- : Referred to the House Committee on Transportation and Infrastructure.
- : Referred to the Subcommittee on Aviation.
- : Introduced in House
Subjects: Transportation employees, Transportation and Public Works, Licensing and registrations, Aviation and airports, Government information and archives, Prescription drugs
Common questions
- What is HB2592?
- HB2592 is a bill in Congress (119th Congress): Aviation Medication Transparency Act of 2025.
- What does HB2592 do?
- In its own words: To require the Administrator of the Federal Aviation Administration to publish the list of medications that the Administrator has compiled for purposes of the medical certification of airmen, and for other purposes.
- What is the status of HB2592?
- In committee as of September 15, 2026. Latest action: Ordered to be Reported (Amended) by Voice Vote. (September 15, 2026).
- Who sponsored HB2592?
- Sean Casten (D, HD-006), with 11 co-sponsors.
- Where is the official record for HB2592?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/2592
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.